Compare Bumi Citra Permai Tbk (BCIP) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bumi Citra Permai Tbk vs Merck Tbk. — how do they compare? Bumi Citra Permai Tbk trades at Rp61 (market cap 84.37B, 89.95M 24h volume), while Merck Tbk. trades at Rp3,740 (market cap 1.68T, 22.8K 24h volume). The key difference: Merck Tbk. is far larger — about 19.9× Bumi Citra Permai Tbk's market cap, and Bumi Citra Permai Tbk is more actively traded (89.95M versus 22.8K). Which is the better fit depends on your goals.
| BCIP | MERK | |
|---|---|---|
Market Cap | 84.37B | 1.68T |
Volume | 89.95M | 22.8K |
Lot | 899.54K | 228 |
Turnover | 5.71B | 82.9M |
Average Price | 63.46 | 3,636.14 |
Value | 5.71B | 82.9M |
Indicative Equilibrium Price | 61 | 3,520 |
Indicative Equilibrium Volume | 10.63K | 60 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bumi Citra Permai Tbk
PT Bumi Citra Permai Tbk (the company) was established on 3 May 2000 based on Notaries Deed No. 2 and the deed of establishment was approved by the the Ministry of Justice dated Sep 7, 2000. The Company’s articles of association has been amended several times, most recently by notarial deed No. 9 of Robert Purba, S.H., dated 6 May, 2009, concerning among others, public offering and issue warrant.
Read more on BCIP →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
